RxDoctor Payments Data

Christopher Ripperda, MD

Urogynecology and Reconstructive Pelvic Surgery · Fort Worth, TXNPI 1790001360

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.8% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Medtronic at 54.7% of the total. Reporting peaked in 2021 at $956 and has fallen 68.3% since, to $303 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in TX, where the typical reported total is $5,014.

$3,553in general payments, 2019–2025

Across 85 payments — averaging $41.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Axonics, Inc.$969
  • Caldera Medical, Inc$314
  • Boston Scientific$271
  • Johnson & Johnson$33
  • Aspira Women's Health Inc$19
  • plus $6 from 1 others

What the payments were for

  • Food & beverage$3,40396%
  • Education$562%
  • Gifts$943%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,553 in reported general payments places this provider in the 40th percentile of 74 urogynecology and reconstructive pelvic surgery providers in Texas.

See all urogynecology and reconstructive pelvic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$321,944
Medicare patients
353
Services billed
1,998

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron156$105,523
MyrbetriqMirabegron40$32,626
Estradiol145$10,758
Fosfomycin Tromethamine39$6,468
Methenamine Hippurate42$2,740
Naloxone Hcl22$1,303
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst29$449
Clobetasol Propionate13$358
Tramadol Hcl108$212
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen33$162
Amitriptyline Hcl13$127
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim16$37

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →